VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 75 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $85 | -100.0% | 10,780 | -91.5% | 0.00% | -100.0% |
| Q1 2021 | $596,000 | +496.0% | 126,600 | +1248.5% | 0.00% | +200.0% |
| Q3 2020 | $100,000 | -65.8% | 9,388 | -59.4% | 0.00% | -50.0% |
| Q2 2020 | $292,000 | +53.7% | 23,116 | +11.2% | 0.00% | 0.0% |
| Q1 2020 | $190,000 | -87.2% | 20,783 | -62.0% | 0.00% | -80.0% |
| Q2 2019 | $1,490,000 | +15.5% | 54,741 | -18.8% | 0.01% | -16.7% |
| Q1 2019 | $1,290,000 | +124.3% | 67,379 | +10.1% | 0.01% | +140.0% |
| Q4 2018 | $575,000 | +160.2% | 61,175 | +423.0% | 0.01% | +150.0% |
| Q3 2018 | $221,000 | -66.0% | 11,697 | -64.9% | 0.00% | -66.7% |
| Q2 2018 | $650,000 | +450.8% | 33,282 | +367.6% | 0.01% | +500.0% |
| Q4 2017 | $118,000 | -79.5% | 7,117 | -74.6% | 0.00% | -80.0% |
| Q3 2017 | $577,000 | +330.6% | 28,029 | +150.4% | 0.01% | +400.0% |
| Q3 2016 | $134,000 | – | 11,195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $37,772,000 | 15.45% |
| EcoR1 Capital, LLC | 4,753,907 | $28,096,000 | 0.97% |
| ARMISTICE CAPITAL, LLC | 2,564,000 | $15,153,000 | 0.26% |
| Harvest Investment Services, LLC | 42,312 | $250,000 | 0.19% |
| Aevitas Wealth Management, Inc. | 22,000 | $130,000 | 0.09% |
| CAXTON ASSOCIATES LP | 136,592 | $807,000 | 0.08% |
| XTX Topco Ltd | 25,525 | $151,000 | 0.06% |
| BVF INC/IL | 140,000 | $827,000 | 0.04% |
| FIDUCIARY TRUST CO | 248,529 | $1,469,000 | 0.03% |
| MYDA Advisors LLC | 12,000 | $71,000 | 0.02% |